Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.

U.S. Court of Appeals for the Federal Circuit

Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.

Opinion

Case: 21-1926 Document: 48 Page: 1 Filed: 03/09/2022

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

AZURITY PHARMACEUTICALS, INC., Plaintiff-Appellant

v.

BIONPHARMA INC., Defendant-Appellee ______________________

2021-1926, 2021-1927 ______________________

Appeals from the United States District Court for the District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19- cv-01067-LPS, Judge Leonard P. Stark. ______________________

JUDGMENT ______________________

RICHARD TORCZON, Wilson, Sonsini, Goodrich & Rosati, PC, Washington, DC, argued for plaintiff-appellant. Also represented by TY WILLIAM CALLAHAN, GRANVILLE CLAYTON KAUFMAN, Los Angeles, CA; WENDY L. DEVINE, NICHOLAS SYLVESTER HALKOWSKI, KRISTINA M. HANSON, San Francisco, CA; NATALIE J. MORGAN, San Diego, CA.

ANDREW M. ALUL, Taft, Stettinius & Hollister, LLP, Chicago, IL, argued for defendant-appellee. Also repre- sented by ROSHAN SHRESTHA. Case: 21-1926 Document: 48 Page: 2 Filed: 03/09/2022

______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, CLEVENGER, and STOLL, Cir- cuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 9, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Reference

Status
Unpublished